INTEGRA Biosciences’ vacuum aspiration systems help researchers solve the dog epigenome

Al­lo­gene­ic CAR-T biotech Cel­lec­tis took its CAR-T man­u­fac­tur­ing in-house af­ter fac­ing “bro­ken” sup­ply chain is­sues with third par­ty man­u­fac­tur­ers, and, ac­cord­ing to the com­pa­ny, the

New Roche CEO Thomas Schi­neck­er is im­ple­ment­ing a re­fined R&D strat­e­gy for the sprawl­ing Swiss con­glom­er­ate in the wake of sev­er­al re­cent late-stage fail­ures. The

The EMA’s CHMP gave a positive opinion for AbbVie’s Skyrizi based on positive data from the Phase III INSPIRE and COMMAND studies. Credit: Valeriya Zankovych